S. Omar Ishrak - 06 Aug 2021 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Director
Signature: /s/ Andrea A. Robinson, Attorney-In-Fact for Dr. Ishrak
Issuer symbol: AMGN
Transactions as of: 06 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Aug 2021, 18:59:09 UTC
Previous filing: 04 Aug 2021
Next filing: 01 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Award	$0	+760	+434%	$0.000000	935	06 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Content

The Restricted Stock Units were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.